Using gene therapy to manipulate the immune system in the fight against B-cell leukemias
Author:
Publisher
Informa Healthcare
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology
Link
http://www.tandfonline.com/doi/pdf/10.1517/14712598.2015.1014792
Reference64 articles.
1. The T-body approach: potential for cancer immunotherapy
2. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors.
3. CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients
4. Signals through T cell receptor-zeta chain alone are insufficient to prime resting T lymphocytes.
5. Chimeric Fv-ζ or Fv-ε receptors are not sufficient to induce activation or cytokine production in peripheral T cells
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chimeric Antigen Receptor T Cells in Tumor Immunology: Opportunities and Challenges;Journal of Nanoscience and Nanotechnology;2016-12-01
2. At The Bedside: Clinical review of chimeric antigen receptor (CAR) T cell therapy for B cell malignancies;Journal of Leukocyte Biology;2016-06-27
3. Human Leukocyte Antigen–Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer;Molecular Cancer Therapeutics;2015-12-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3